242 related articles for article (PubMed ID: 30395906)
1. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
3. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
4. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
[TBL] [Abstract][Full Text] [Related]
5. Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.
Unkelbach J; Botas P; Giantsoudi D; Gorissen BL; Paganetti H
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1097-1106. PubMed ID: 27869082
[TBL] [Abstract][Full Text] [Related]
6. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
Wedenberg M; Toma-Dasu I
Med Phys; 2014 Sep; 41(9):091706. PubMed ID: 25186381
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
[TBL] [Abstract][Full Text] [Related]
8. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
9. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
10. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
[TBL] [Abstract][Full Text] [Related]
11. Incorporating variable RBE in IMPT optimization for ependymoma.
Goudarzi HM; Lim G; Grosshans D; Mohan R; Cao W
J Appl Clin Med Phys; 2024 Jan; 25(1):e14207. PubMed ID: 37985962
[TBL] [Abstract][Full Text] [Related]
12. Proposing a Clinical Model for RBE Based on Proton Track-End Counts.
Henthorn NT; Gardner LL; Aitkenhead AH; Rowland BC; Shin J; Smith EAK; Merchant MJ; Mackay RI; Kirkby KJ; Chaudhary P; Prise KM; McMahon SJ; Underwood TSA
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):916-926. PubMed ID: 36642109
[TBL] [Abstract][Full Text] [Related]
13. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
14. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
15. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
16. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
Frese MC; Wilkens JJ; Huber PE; Jensen AD; Oelfke U; Taheri-Kadkhoda Z
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):80-8. PubMed ID: 20382482
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
[TBL] [Abstract][Full Text] [Related]
19. Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.
Wan Chan Tseung HS; Ma J; Kreofsky CR; Ma DJ; Beltran C
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1535-1543. PubMed ID: 27325476
[TBL] [Abstract][Full Text] [Related]
20. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
